ES8602820A1 - Procedimiento para la preparacion de derivados de tiazolidina - Google Patents

Procedimiento para la preparacion de derivados de tiazolidina

Info

Publication number
ES8602820A1
ES8602820A1 ES533624A ES533624A ES8602820A1 ES 8602820 A1 ES8602820 A1 ES 8602820A1 ES 533624 A ES533624 A ES 533624A ES 533624 A ES533624 A ES 533624A ES 8602820 A1 ES8602820 A1 ES 8602820A1
Authority
ES
Spain
Prior art keywords
preparation
thiazolidine derivatives
pharmaceutical preparations
hydrogen
intermediates therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES533624A
Other languages
English (en)
Other versions
ES533624A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8602820A1 publication Critical patent/ES8602820A1/es
Publication of ES533624A0 publication Critical patent/ES533624A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE TIAZOLIDINA. COMPRENDE TRATAR UN COMPUESTO DE FORMULA GENERAL (II), EN LA QUE X SIGNIFICA METILENO, OXIGENO O AZUFRE, R2 SIGNIFICA HALOGENO O HIDROGENO, CON UN ACIDO FUERTE COMO ELCLORHIDRICO ACUOSO ALCOHOLICO MIENTRAS SE CALIENTA HASTA LA TEMPERATURA DE REFLUJO LA REACCION PARA OBTENER LOS COMPUESTOS DE FORMULA (I). DE APLICACION EN EL TRATAMIENTO DE LA DIABETES MELLITUS Y PARA LA PREVENCION DE CATARATAS Y NEUROPATIAS.
ES533624A 1983-06-23 1984-06-22 Procedimiento para la preparacion de derivados de tiazolidina Granted ES533624A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH343283 1983-06-23
CH186084 1984-04-13

Publications (2)

Publication Number Publication Date
ES8602820A1 true ES8602820A1 (es) 1985-12-16
ES533624A0 ES533624A0 (es) 1985-12-16

Family

ID=25688868

Family Applications (4)

Application Number Title Priority Date Filing Date
ES533624A Granted ES533624A0 (es) 1983-06-23 1984-06-22 Procedimiento para la preparacion de derivados de tiazolidina
ES541705A Granted ES541705A0 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.
ES541708A Expired ES8602719A1 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.
ES541707A Expired ES8602718A1 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES541705A Granted ES541705A0 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.
ES541708A Expired ES8602719A1 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.
ES541707A Expired ES8602718A1 (es) 1983-06-23 1985-03-29 Procedimiento para la preparacion de derivados de tiazolidina.

Country Status (11)

Country Link
US (1) US4587256A (es)
EP (1) EP0129747A3 (es)
AU (1) AU2947784A (es)
DK (1) DK277484A (es)
ES (4) ES533624A0 (es)
FI (1) FI842327A (es)
HU (1) HUT34509A (es)
IL (1) IL72139A0 (es)
MC (1) MC1601A1 (es)
NO (1) NO842515L (es)
PT (1) PT78778B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
JPH06772B2 (ja) * 1984-07-09 1994-01-05 鐘淵化学工業株式会社 ３―（４―フルオロフエノキシ）プロピオニトリルを用いる６―フルオロ―４―クロマノンの製造法
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
CN100595204C (zh) * 1999-12-22 2010-03-24 症变治疗公司 双氨基化膦酸酯前药
US7563774B2 (en) * 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
MY148480A (en) * 2004-05-24 2013-04-30 Amgen Inc Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
US8686011B2 (en) 2004-05-24 2014-04-01 Amgen Inc. Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
EP1778250A2 (en) * 2004-08-18 2007-05-02 Metabasis Therapeutics, Inc. Novel thiazole inhibitors of fructose 1,6-bisphosphatase
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
CN115322208B (zh) * 2021-05-10 2023-04-11 中国药科大学 2-氨基噻唑类衍生物及其制备方法和医药用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210756A (en) * 1976-10-18 1980-07-01 Pfizer Inc. Tetrahydroquinoline hydantoins for chronic diabetic complications
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines

Also Published As

Publication number Publication date
NO842515L (no) 1984-12-27
IL72139A0 (en) 1984-10-31
ES541708A0 (es) 1985-12-01
AU2947784A (en) 1985-01-03
ES541707A0 (es) 1985-12-01
MC1601A1 (fr) 1985-05-09
PT78778A (en) 1984-07-01
EP0129747A2 (de) 1985-01-02
ES533624A0 (es) 1985-12-16
ES8602719A1 (es) 1985-12-01
ES8602716A1 (es) 1985-12-01
ES541705A0 (es) 1985-12-01
DK277484A (da) 1984-12-24
DK277484D0 (da) 1984-06-04
EP0129747A3 (de) 1985-09-25
US4587256A (en) 1986-05-06
FI842327A0 (fi) 1984-06-08
FI842327A (fi) 1984-12-24
PT78778B (en) 1986-09-15
HUT34509A (en) 1985-03-28
ES8602718A1 (es) 1985-12-01

Similar Documents

Publication Publication Date Title
MA20459A1 (fr) Derives de l'imidazol-1,5-a/-pyridine substitues
NZ212750A (en) 3-acylamino-2-azetidinone derivatives useful as intermediates in the preparation of antibacterial agents
ES8602719A1 (es) Procedimiento para la preparacion de derivados de tiazolidina.
ES8503339A1 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
DE3666226D1 (en) Process for the preparation of 1,2-dithiolan-3-pentanoic acid (thioctic acid)
AU582043B2 (en) Phenoxyalkylcarboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
DK72686A (da) Aminosyrederivat og antikonvulsant praeparat som indeholder derivatet
ES8504718A1 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
FR2443471A1 (fr) Derives du type thiazolidine de la progesterone utiles notamment comme precurseurs de medicaments antiacne et antiseborrhee
BG42835A3 (en) Method for preparing derivatives of thiazolylacetic acid
DE3782207D1 (de) 2-acyloxypropylamin-derivate, verfahren zur herstellung und diese enthaltende arzneimittel.
ATE30152T1 (de) 1-methyl-5-nitro-imidazolin-derivate und diese enthaltende therapeutische zusammensetzungen.
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE48424T1 (de) Esterderivate von 2-alpha-hydroxy-substituierter 4-hydroxy-3-chinolincarbonsaeure, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ATE33837T1 (de) Azolylmethylcycloacetale, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES8602797A1 (es) Procedimiento para preparar 11-piperazinil-5h-imidazo(2, 1-c) (1, 4) benzodiazepinas
SE8501993D0 (sv) New apovincaminol derivatives, process for their preparation and pharmaceutical compositions containing them
AU579416B2 (en) 3-Amino-2,3-dihydro-1-benzoxepine-compounds and methods for their preparation and pharmaceutical preparations containing these compounds
DE3361834D1 (en) Dithiino (1,4) (2,3-c) pyrrole derivatives, their preparation and pharmaceutical compositions containing them